Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: LYM126
MIFTS: 32

Lymphoma Aids Related

Categories: Immune diseases, Rare diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Lymphoma Aids Related

About this section

MalaCards integrated aliases for Lymphoma Aids Related:

Name: Lymphoma Aids Related 53
Lymphoma, Aids-Related 17 72
Aids Related Lymphoma 53
Lymphoma Aids-Related 55

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Immune diseases
See all MalaCards categories (disease lists)


External Ids:

UMLS 72 C0085090
Sources

Summaries for Lymphoma Aids Related

About this section
MalaCards based summary : Lymphoma Aids Related, also known as lymphoma, aids-related, is related to primary effusion lymphoma and lymphoma. An important gene associated with Lymphoma Aids Related is BCL6 (BCL6 Transcription Repressor), and among its related pathways/superpathways are Cytokine Signaling in Immune system and PI3K-Akt signaling pathway. The drugs Ketamine and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include b cells, liver and brain, and related phenotype is no phenotypic analysis.

Sources

Related Diseases for Lymphoma Aids Related

About this section

Diseases related to Lymphoma Aids Related via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 71)
# Related Disease Score Top Affiliating Genes
1 primary effusion lymphoma 31.3 TCL1A MYC BCL6
2 lymphoma 29.4 TCL1A MYC BCL6
3 burkitt lymphoma 29.3 TCL1A MYC BCL6
4 peripheral t-cell lymphoma 29.2 TCL1A BCL6
5 acquired immunodeficiency syndrome 29.2 MYC BCL6
6 plasmablastic lymphoma 29.2 MYC BCL6
7 diffuse large b-cell lymphoma 29.1 MYC BCL6
8 follicular lymphoma 29.0 MYC BCL6
9 leukemia, chronic lymphocytic 28.8 TCL1A IL7 BCL6
10 lymphoma, non-hodgkin, familial 28.6 TCL1A MYC BCL6
11 immune deficiency disease 10.0
12 neutropenia 10.0
13 autoimmune lymphoproliferative syndrome, type v 9.9 TCL1A BCL6
14 kaposi sarcoma 9.9
15 lymphoma, hodgkin, classic 9.9
16 human immunodeficiency virus type 1 9.9
17 human herpesvirus 8 9.9
18 b-cell non-hodgkin lymphoma 9.9
19 high grade b-cell lymphoma with myc and/ or bcl2 and/or bcl6 rearrangement 9.8 MYC BCL6
20 primary mediastinal large b-cell lymphoma 9.8 MYC BCL6
21 leukemia, acute myeloid 9.7
22 myelodysplastic syndrome 9.7
23 anaplastic large cell lymphoma 9.7
24 persistent generalized lymphadenopathy 9.7
25 lymphoblastic lymphoma 9.7
26 multicentric castleman disease 9.7
27 castleman disease 9.7
28 lymphocytic leukemia 9.7
29 sarcoma 9.7
30 lymphadenitis 9.7
31 pneumothorax 9.7
32 hepatitis c 9.7
33 central nervous system lymphoma 9.7
34 central nervous system disease 9.7
35 spindle cell sarcoma 9.7
36 cerebral lymphoma 9.7
37 paraplegia 9.7
38 severe combined immunodeficiency 9.7
39 combined t cell and b cell immunodeficiency 9.7
40 lung lymphoma 9.7
41 b-cell lymphoma 9.7
42 t-cell leukemia 9.7
43 lung disease 9.7
44 hodgkin's lymphoma, lymphocytic-histiocytic predominance 9.7
45 nervous system disease 9.7
46 neuropathy 9.7
47 stomatitis 9.7
48 47,xyy 9.7
49 chromosomal triplication 9.7
50 fibromatosis 9.7

Graphical network of the top 20 diseases related to Lymphoma Aids Related:



Diseases related to Lymphoma Aids Related
Sources

Symptoms & Phenotypes for Lymphoma Aids Related

About this section

MGI Mouse Phenotypes related to Lymphoma Aids Related:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 no phenotypic analysis MP:0003012 8.8 BCL6 IL7 MYC
Sources

Drugs & Therapeutics for Lymphoma Aids Related

About this section

Drugs for Lymphoma Aids Related (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 187)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
2
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
3
Guaifenesin Approved, Investigational, Vet_approved Phase 3 93-14-1 3516
4
Morphine Approved, Investigational Phase 3 57-27-2 5288826
5
Mercaptopurine Approved Phase 3 50-44-2 667490
6
Cobalt Approved, Experimental Phase 3 7440-48-4 104729
7
Dextromethorphan Approved Phase 3 125-71-3 5360696 5362449
8
Caspofungin Approved Phase 3 179463-17-3, 162808-62-0 468682 2826718
9
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
10
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
11
St. John's Wort Approved, Investigational, Nutraceutical Phase 3 84082-80-4
12 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
13 Anesthetics, Dissociative Phase 3
14 Anti-Infective Agents Phase 3
15 Antidotes Phase 3
16 Protective Agents Phase 3
17 Antiparasitic Agents Phase 3
18 Antiprotozoal Agents Phase 3
19 Analgesics Phase 3
20 Antifungal Agents Phase 3
21 Narcotics Phase 3
22 Respiratory System Agents Phase 3
23 Chlorpheniramine, phenylpropanolamine drug combination Phase 3
24 Antitussive Agents Phase 3
25 Micronutrients Phase 3
26 Trace Elements Phase 3
27 Vitamins Phase 3
28 Nutrients Phase 3
29 Anesthetics, Intravenous Phase 3
30 Excitatory Amino Acid Antagonists Phase 3
31 Anesthetics Phase 3
32 Anesthetics, General Phase 3
33 Excitatory Amino Acids Phase 3
34 Liver Extracts Phase 3
35 Cola Phase 3
36 Liposomal amphotericin B Phase 3
37 Adjuvants, Anesthesia Phase 3
38
Mitoxantrone Approved, Investigational Phase 1, Phase 2 65271-80-9 4212
39
Valproic acid Approved, Investigational Phase 2 99-66-1 3121
40
Epirubicin Approved Phase 2 56420-45-2 41867
41
Vinblastine Approved Phase 2 865-21-4 241903 13342
42
Carmustine Approved, Investigational Phase 2 154-93-8 2578
43
Bleomycin Approved, Investigational Phase 2 11056-06-7 5360373
44
Gallium nitrate Approved, Investigational Phase 2 13494-90-1 61635
45
Sargramostim Approved, Investigational Phase 2 83869-56-1, 123774-72-1
46
Trimethoprim Approved, Vet_approved Phase 2 738-70-5 5578
47
Allopurinol Approved Phase 2 315-30-0 2094
48
Sulfamethoxazole Approved Phase 2 723-46-6 5329
49
Zidovudine Approved Phase 2 30516-87-1 35370
50
Fluorouracil Approved Phase 2 51-21-8 3385

Interventional clinical trials:

(show top 50) (show all 100)
# Name Status NCT ID Phase Drugs
1 A Randomized Double-Blind Controlled Trial of Ketamine Versus Placebo in Conjunction With Best Pain Management in Neuropathic Pain in Cancer Patients Unknown status NCT01316744 Phase 3 ketamine hydrochloride
2 Randomized Trial of CHOP Chemotherapy With or Without Rituximab (Chimeric Anti-CD20 Antibody) for HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003595 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
3 A Phase III Study of Large Cell Lymphomas in Children and Adolescents: Comparison of APO vs APO + IDMTX/HDARA-C and Continuous vs Bolus Infusion of Doxorubicin Completed NCT00002618 Phase 3 cytarabine;doxorubicin hydrochloride;leucovorin calcium;mercaptopurine;methotrexate;prednisone;vincristine sulfate
4 Preparatory Aid to Improve Decision Making About Cancer Clinical Trials (PRE-ACT) Completed NCT00750009 Phase 3
5 A Double-Blind Study Of Nutritional Intervention For The Treatment Of Cancer Cachexia Using Juven® Nutritional Supplement Completed NCT00053053 Phase 3
6 Phase III, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Ondansetron in the Control of Chronic Nausea and Vomiting Not Due to Antineoplastic Therapy in Patients With Advanced Cancer Completed NCT00006348 Phase 3 ondansetron
7 A Phase III Double-Blind Equivalence Study of Two Different Formulations of Slow-Release Morphine Followed by a Randomization Between Dextromethorphan or Placebo Plus Statex SR for Chronic Cancer Pain Relief in Terminally Ill Patients Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
8 Does Hypericum Reduce Fatigue in Cancer Patients on Chemotherapy? A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Completed NCT00005805 Phase 3
9 A Multicenter, Double-Blind, Randomized, Comparative Study To Evaluate The Safety, Tolerability, And Efficacy Of MK-0991 Versus (Amphotericin B) Liposome For Injection As Empirical Therapy In Patients With Persistent Fever And Neutropenia Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
10 A Randomized, Double-blind, Placebo-controlled Multi-center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
11 A Phase I/II Study of the Safety and Feasibility of REVM10 or REVM10/ANTISENSE POL 1 Transduced Hematopoietic Stem Cells (HSC) in HIV-1 Related Non-Hodgkin's Lymphoma Patients Already Being Treated With High Dose Chemotherapy and Peripheral Blood Stem Cell Support Unknown status NCT00003942 Phase 1, Phase 2
12 Pilot Study Of PMitCEBO Plus G-CSF In Good-Prognosis HIV-Related Lymphoma Unknown status NCT00032149 Phase 1, Phase 2 cyclophosphamide;etoposide;mitoxantrone hydrochloride;prednisolone;vincristine sulfate
13 Epigenetic Therapy With Valproic Acid, an HDAC Inhibitor, in Refractory/Relapsed Non-Hodgkin Lymphoma, Hodgkin's Disease and CLL Unknown status NCT01016990 Phase 2 valproic acid
14 Treatment of HIV-Related Primary Central Nervous System Lymphoma (HIV-PCNSL): A Phase II Trial With Neoadjuvant Chemotherapy (High-Dose Methotrexate (MTX) Plus High-Dose Zidovudine) and Radiotherapy Unknown status NCT00003261 Phase 2 methotrexate;zidovudine
15 Prospective Non Randomized Study With Chemotherapy in Patients With Hodgkin's Disease and HIV Infection: "Stanford V Regimen" For "Low Risk" Patients, "EBVP Regimen" For "High Risk" Patients Unknown status NCT00003262 Phase 2 Stanford V regimen;doxorubicin hydrochloride;epirubicin hydrochloride;etoposide;mechlorethamine hydrochloride;prednisone;vinblastine sulfate;vincristine sulfate
16 Pilot Study of the Safety and Feasibility of Autologous Peripheral Blood Stem Cell Transplantation for Patients With Relapsed AIDS-Related Lymphoma Completed NCT00005824 Phase 2 busulfan;cyclophosphamide
17 A Phase II Study of Doxil (Liposomal Doxorubicin), Cyclophosphamide, Vincristine and Prednisone for AIDS-Related Systemic Lymphoma Completed NCT00003388 Phase 2 cyclophosphamide;cytarabine;methotrexate;pegylated liposomal doxorubicin hydrochloride;prednisone;vincristine sulfate
18 Phase II Evaluation of Gallium Nitrate (NSC 15200) in Non-Hodgkin's Lymphoma in Patients With Acquired Immunodeficiency Syndrome Completed NCT00002578 Phase 2 cytarabine;gallium nitrate;leucovorin calcium;methotrexate
19 Study of Promace-Cytabom With Trimethoprim Sulfamethoxazole, Zidovudine (AZT), and Granulocyte Colony Stimulating Factor (G-CSF) in Patients With AIDS-Related Lymphoma, Phase II Completed NCT00002571 Phase 2 cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;leucovorin calcium;methotrexate;prednisone;trimethoprim-sulfamethoxazole;vincristine sulfate;Intrathecal cytarabine
20 EPOCH Chemotherapy Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma Completed NCT00001563 Phase 2 EPOCH
21 Pilot Study in AIDS-Related Lymphomas Completed NCT00002524 Phase 2 Cisplatin;Cyclophosphamide;Cytarabine;Doxorubicin Hydrochloride (DOX);Etoposide;Fluorouracil;Ifosfamide;Leucovorin calcium;Methotrexate;Methylprednisolone;Pentamidine;Prednisone;Trimethoprim-Sulfamethoxazole;Vincristine Sulfate;Zidovudine (AZT)
22 A Phase II Trial of 72-Hour Continuous Infusion Bleomycin as Salvage Therapy in AIDS-Related and Immunocompetent Non-Hodgkin's Lymphoma Completed NCT00003110 Phase 2
23 High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT Completed NCT00858793 Phase 1, Phase 2
24 Dose-Modified Oral Combination Chemotherapy In Patients With Aids-Related Non-Hodgkin's Lymphoma In The United States And Africa Completed NCT00049439 Phase 2 cyclophosphamide;etoposide;lomustine;procarbazine hydrochloride
25 Phase II Evaluation of Mitoguazone Dihydrochloride in Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma Associated With Acquired Immunodeficiency Syndrome Completed NCT00002348 Phase 2 Mitoguazone
26 Feasibility Study of CO-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of Acquired Immunodeficiency Syndrome (AIDS)-Related Lymphoma Completed NCT00799136 Phase 2 R-EPOCH and cART
27 A Randomized Pre-Phase II Trial of Interleukin-2, Interleukin-12, or No Additional Therapy Following Response to Ifosfamide/Etoposide Chemotherapy for Refractory HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003575 Phase 2 etoposide;ifosfamide
28 Hydroxyurea Treatment of EBV-Associated Primary CNS Lymphoma in Children and Adults With AIDS Completed NCT00002940 Phase 2 hydroxyurea
29 First Line Treatment in HIV-related Large Cell Non Hodgkin Lymphoma at "High Risk", Including Early Consolidation With High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation Completed NCT01045889 Phase 2
30 A Phase II Trial Of Induction Therapy With Zidovudine, Interleukin-2, And Ganciclovir In The Treatment Of HIV Positive Primary Central Nervous System Lymphoma Completed NCT00006264 Phase 2 ganciclovir;zidovudine
31 A Phase II Trial of Doxil, Rituximab, Cyclophosphamide, Vincristine, and Prednisone (DR-COP) in Patients With Newly Diagnosed AIDS-Associated B-Cell Non-Hodgkin's Lymphoma Completed NCT00389818 Phase 2 cyclophosphamide;pegylated liposomal doxorubicin hydrochloride;prednisone;vincristine sulfate
32 A Phase II Study of Alpha Interferon (alphaIFN) In HIV-Related Malignancies - A Pediatric Oncology Group Wide Study Completed NCT00002621 Phase 2
33 The Effect of Cyproheptadine Hydrochloride (Periactin) and Megestrol Acetate (Megace) on Weight in Children With Cancer/Treatment Related Cachexia Completed NCT00066248 Phase 2 cyproheptadine hydrochloride;megestrol acetate
34 High Dose Chemotherapy and Autologous Peripheral Stem Cell Transplantation for HIV Lymphomas: A Phase IIA Study of Comparative Marking Using a Ribozyme Gene and a Neutral Gene Completed NCT00002221 Phase 2 Peripheral blood stem cells
35 RC05CB A Pilot, Randomized Comparison of Standard Weekly Epoetin Alfa to Every-3-Week-Epoetin Alfa and Every 3-Week Darbepoetin Alfa Completed NCT00416624 Phase 2 darbepoetin alfa;epoetin alfa
36 Assessment of Early and Standard Intervention With Procrit® (Epoetin Alfa) 120,000 Units Once Every Three Weeks (Q3W) in Patients With Cancer Receiving Chemotherapy Completed NCT00255749 Phase 2
37 A Phase I-II Intensive-Dose Ifosfamide, Carboplatin and Taxotere (IC-T) Combination Chemotherapy Followed by Autologous Stem Cell Rescue for Patients With Refractory Malignancies Completed NCT00003406 Phase 1, Phase 2 carboplatin;docetaxel;ifosfamide
38 An Evaluation of the Toxicity and Therapeutic Effects of Epstein-Barr Virus-Immune T-Lymphocytes Derived From a Normal HLA-Compatible or Haplotype-Matched Donor in the Treatment of EBV-Associated Lymphoproliferative Diseases or Malignancies and Patients With Detectable Circulating Levels of EBV DNA Who Are at High Risk for EBV-Associated Lymphoproliferative Diseases Completed NCT00002663 Phase 1, Phase 2
39 Prospective Phase II Study of a High Dose, Short Course Regimen (R-CODOX-M/IVAC) Including CNS Penetration and Intensive IT Prophylaxis in HIV-Associated Burkitt's and Atypical Burkitt's Lymphoma Completed NCT00392834 Phase 2 cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;ifosfamide;leucovorin calcium;liposomal cytarabine;methotrexate;therapeutic hydrocortisone;vincristine sulfate
40 Oral Combination Chemotherapy in the Treatment of AIDS-Associated Hodgkin's Disease Completed NCT00003114 Phase 2 cyclophosphamide;etoposide;lomustine;procarbazine hydrochloride
41 High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN #0803) Completed NCT01141712 Phase 2 BCNU;Etoposide;Cytarabine;Melphalan
42 AIDS-Related Primary Central Nervous System Lymphoma: A Phase II Pilot Study of High-Dose Intravenous Methotrexate With Rituximab Leucovorin Rescue and Highly Active Antiretroviral Therapy Recruiting NCT00267865 Phase 2 Methotrexate;Rituximab;Leucovorin
43 Short-Course EPOCH-Rituximab in Untreated CD-20+ HIV-Associated Lymphomas Recruiting NCT00006436 Phase 2 EPOCH
44 Phase I/II Study of Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R(2)) In Primary Effusion Lymphoma or KSHV-Associated Large Cell Lymphoma Recruiting NCT02911142 Phase 1, Phase 2 Lenalidomide;Rituximab;Prednisone;Etopside;Doxorubicin;Vincristine;Cyclophosphamide
45 Randomized, Phase II Trial of CHOP vs. Oral Chemotherapy With Concomitant Antiretroviral Therapy in Patients With HIV-Associated Lymphoma in Sub-Saharan Africa Active, not recruiting NCT01775475 Phase 2 cyclophosphamide;doxorubicin hydrochloride;vincristine sulfate;prednisone;lomustine;etoposide;cyclophosphamide;procarbazine hydrochloride
46 A Multicenter Phase II Study Incorporating DOXIL® and Rituximab Into the Magrath Regimen for HIV-Negative and HIV-Positive Patients With Newly Diagnosed Burkitt's and Burkitt-like Lymphoma Active, not recruiting NCT00392990 Phase 2 Regimen A;Regimen B
47 Multicenter, Open Label, Phase II Trial to Evaluate the Efficacy and Safety of Treatment With Rituximab + CHOP Regimen in Patients With HIV Related Non-Hodgkin’s Lymphomas. ANRS 085 Rituximab Terminated NCT00126243 Phase 2 rituximab;CHOP
48 Phase II Study of Induction Therapy Comprising Etoposide, Methylprednisolone, Cytarabine, and Cisplatin (ESHAP) Followed by Consolidation Therapy Comprising Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma Withdrawn NCT00310128 Phase 2 cisplatin;cytarabine;etoposide;methylprednisolone;rituximab;yttrium Y 90 ibritumomab tiuxetan
49 A Phase II Study of Phenylbutyrate and Valganciclovir in Epstein-Barr Virus Positive Tumors Withdrawn NCT00387530 Phase 2 oral sodium phenylbutyrate;valganciclovir
50 Combined Modality Therapy of AIDS-Related and Immunocompetent Primary CNS Lymphoma (PCL) Using Filgrastim (G-CSF) Withdrawn NCT00003929 Phase 2 lomustine;procarbazine hydrochloride

Search NIH Clinical Center for Lymphoma Aids Related

Sources

Genetic Tests for Lymphoma Aids Related

About this section
Sources

Anatomical Context for Lymphoma Aids Related

About this section

MalaCards organs/tissues related to Lymphoma Aids Related:

41
B Cells, Liver, Brain, Bone, Bone Marrow, T Cells
Sources

Publications for Lymphoma Aids Related

About this section

Articles related to Lymphoma Aids Related:

(show all 12)
# Title Authors PMID Year
1
A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma. 38
21406721 2011
2
Overexpression of Yin Yang 1 in the pathogenesis of human hematopoietic malignancies. 38
22248059 2011
3
Factors associated with mortality among HIV-infected patients in the era of highly active antiretroviral therapy in southern India. 38
19632872 2010
4
T-cell immune reconstitution after hematopoietic stem cell transplantation for HIV-associated lymphoma. 9
16177644 2005
5
BCL-6 mutations in pulmonary lymphoproliferative disorders: demonstration of an aberrant immunological reaction in HIV-related lymphoid interstitial pneumonia. 9
15153535 2004
6
Simian AIDS-related lymphoma growth in severe combined immunodeficiency mice is independent of karyotypic abnormalities or Bcl-6 mutations. 9
11897040 2002
7
TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma. 9
11304575 2001
8
TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues. 9
10449776 1999
9
BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implications. 9
9720713 1998
10
Involvement of the bcl-6 gene in AIDS-related lymphomas. 9
9209652 1997
11
Lymphoma complicating immunodeficiency disorders. 9
8204517 1994
12
AIDS-related lymphomas: evaluation by abdominal CT. 38
3952331 1986
Sources

Variations for Lymphoma Aids Related

About this section
Sources

Expression for Lymphoma Aids Related

About this section
Search GEO for disease gene expression data for Lymphoma Aids Related.
Sources

Pathways for Lymphoma Aids Related

About this section

Pathways related to Lymphoma Aids Related according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Cytokine Signaling in Immune system 66
Show member pathways
 12.65 MYC IL7 BCL6
2
PI3K-Akt signaling pathway 37
Show member pathways
 11.97 TCL1A MYC IL7
3
B cell receptor signaling pathway (KEGG) 1
Show member pathways
 11.8 MYC BCL6
4
Transcriptional misregulation in cancer 37
11.59 MYC BCL6
5
DNA Damage Response (only ATM dependent) 1
11.32 MYC BCL6
6
Interleukin-4 and 13 signaling 66
11.21 MYC BCL6
7
IL-7 Signaling Pathway 1
Show member pathways
 10.29 MYC IL7
Sources

GO Terms for Lymphoma Aids Related

About this section

Biological processes related to Lymphoma Aids Related according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of cell proliferation GO:0008284 9.5 TCL1A MYC IL7
2 regulation of gene expression GO:0010468 9.37 MYC IL7
3 cytokine-mediated signaling pathway GO:0019221 9.33 MYC IL7 BCL6
4 positive regulation of B cell proliferation GO:0030890 9.26 IL7 BCL6
5 positive regulation of mitochondrial membrane potential GO:0010918 8.96 TCL1A MYC
6 negative regulation of apoptotic process GO:0043066 8.92 TCL1A MYC IL7 BCL6

Molecular functions related to Lymphoma Aids Related according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 DNA-binding transcription repressor activity, RNA polymerase II-specific GO:0001227 8.62 MYC BCL6
Sources

Sources for Lymphoma Aids Related

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....